From a basic and mechanistic standpoint, an important result of the study regards the specific involvement of the retinoid receptor RARβ in the anti-tumor action exerted by all-trans retinoic acid in sensitive triple-negative breast cancer cells. The gene discussed is RARB; the disease is triple-negative breast carcinoma.